We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gottlieb: FDA Critics Haven't Skewed Rx Oversight Duties
Gottlieb: FDA Critics Haven't Skewed Rx Oversight Duties
August 26, 2005
Criticism of the FDA’s handling of recent drug-safety issues has not made the agency too conservative in its oversight of drugs, but attacks on advisory committee members could affect the FDA’s ability to hold frank scientific discussions, says a top agency official.